Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy

被引:86
作者
Lee, JM
Yin, KJ
Hsin, I
Chen, SW
Fryer, JD
Holtzman, DM
Hsu, CY
Xu, J
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO USA
[3] Taipei Med Univ, Taipei, Taiwan
关键词
D O I
10.1002/ana.10671
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined the potential role of the extra-cellular matrix-degrading enzyme, matrix metalloproteinase-9 (MMP-9), in the pathogenesis of cerebral amyloid angiopathy (CAA)-induced spontaneous hemorrhage. The amyloid-beta peptide (Abeta) induced the synthesis, release and activation of MMP-9 in murine cerebral endothelial cells, resulting in increased extracellular matrix degradation. Furthermore, extensive MMP-9 immunoreactivity was observed in CAA-vessels with evidence of microhemorrhage in aged APPsw transgenic mice, but not detected in aged wild type or young APPsw mice. These results suggest that increased vascular MMP-9 expression, stimulated by AP, may play a role in the pathogenesis of spontaneous intracerebral hemorrhage in patients with CAA.
引用
收藏
页码:379 / 382
页数:4
相关论文
共 21 条
[1]   Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid [J].
Calhoun, ME ;
Burgermeister, P ;
Phinney, AL ;
Stalder, M ;
Tolnay, M ;
Wiederhold, KH ;
Abramowski, D ;
Sturchler-Pierrat, C ;
Sommer, B ;
Staufenbiel, M ;
Jucker, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :14088-14093
[2]  
Coria F, 1996, NEUROPATH APPL NEURO, V22, P216
[3]  
Deb S, 1996, J NEUROCHEM, V66, P1641
[4]   Matrix metalloproteinases in vascular remodeling and atherogenesis - The good, the bad, and the ugly [J].
Galis, ZS ;
Khatri, JJ .
CIRCULATION RESEARCH, 2002, 90 (03) :251-262
[5]   Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: A possible role in blood-brain barrier dysfunction [J].
Gasche, Y ;
Fujimura, M ;
Morita-Fujimura, Y ;
Copin, JC ;
Kawase, M ;
Massengale, J ;
Chan, PH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (09) :1020-1028
[6]   Cerebral amyloid angiopathy - Prospects for clinical diagnosis and treatment [J].
Greenberg, SM .
NEUROLOGY, 1998, 51 (03) :690-694
[7]  
Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.3.CO
[8]  
2-#
[9]   Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice [J].
Hsiao, K ;
Chapman, P ;
Nilsen, S ;
Eckman, C ;
Harigaya, Y ;
Younkin, S ;
Yang, FS ;
Cole, G .
SCIENCE, 1996, 274 (5284) :99-102
[10]   Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke [J].
Lapchak, PA ;
Chapman, DF ;
Zivin, JA .
STROKE, 2000, 31 (12) :3034-3039